We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$1.25T
AUM Growth
+$112B
Cap. Flow
+$14.2B
Cap. Flow %
1.14%
Top 10 Hldgs %
19.22%
Holding
8,146
New
340
Increased
3,230
Reduced
3,352
Closed
318

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$1.42B
2
IWM icon
iShares Russell 2000 ETF
IWM
+$1.3B
3
UBER icon
Uber
UBER
+$1.25B
4
RTX icon
RTX Corp
RTX
+$1.08B
5
DHR icon
Danaher
DHR
+$771M

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.3%
2 Technology 21.37%
3 Financials 10.81%
4 Healthcare 9.76%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHSI
6651
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$5.95K ﹤0.01%
659
RVP icon
6652
Retractable Technologies
RVP
$20.4M
$5.95K ﹤0.01%
4,955
-2,104
-30% -$2.56K
TRIB
6653
Trinity Biotech
TRIB
$5.72M
$5.94K ﹤0.01%
97
FOCT icon
6654
FT Vest US Equity Buffer ETF October
FOCT
$1.19B
$5.92K ﹤0.01%
+146
New +$5.8K
BODI icon
6655
The Beachbody Company
BODI
$36.6M
$5.88K ﹤0.01%
613
-1,392
-69% -$13.2K
BNDD icon
6656
Quadratic Deflation ETF
BNDD
$17.7M
$5.88K ﹤0.01%
49
OGG
6657
Osisko Gold Group
OGG
$807M
$5.86K ﹤0.01%
2,749
BUXX icon
6658
Strive Enhanced Income Short Maturity ETF
BUXX
$467M
$5.84K ﹤0.01%
+289
New +$5.85K
RGS icon
6659
Regis Corp
RGS
$69M
$5.81K ﹤0.01%
774
-65
-8% -$634
VGAS icon
6660
Verde Clean Fuels
VGAS
$29.5M
$5.8K ﹤0.01%
1,451
-9,539
-87% -$32.2K
NHTC icon
6661
Natural Health Trends
NHTC
$12.9M
$5.8K ﹤0.01%
866
+9
+1% +$56
YARW
6662
Yarrow Bioscience
YARW
$69.3M
$5.74K ﹤0.01%
37
FAAR icon
6663
First Trust Alternative Absolute Return Strategy ETF
FAAR
$219M
$5.67K ﹤0.01%
196
+53
+37% +$1.49K
VWE
6664
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$5.65K ﹤0.01%
15,696
XSHD icon
6665
Invesco S&P SmallCap High Dividend Low Volatility ETF
XSHD
$67.8M
$5.64K ﹤0.01%
366
PNBK icon
6666
Patriot National Bancorp
PNBK
$109M
$5.63K ﹤0.01%
1,500
LATG
6667
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
$5.62K ﹤0.01%
500
LDTC
6668
DELISTED
LeddarTech
LDTC
$5.6K ﹤0.01%
2,000
-720
-26% -$2.75K
FLKR icon
6669
Franklin FTSE South Korea ETF
FLKR
$1.63B
$5.59K ﹤0.01%
239
+238
+23,800% +$5.26K
BEST
6670
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$5.57K ﹤0.01%
2,532
-186
-7% -$424
TLIS
6671
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$5.56K ﹤0.01%
635
+264
+71% +$2.18K
CMCA
6672
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
$5.47K ﹤0.01%
500
DMRA
6673
Damora Therapeutics
DMRA
$1.51B
$5.46K ﹤0.01%
+280
New +$4.98K
XELB icon
6674
Xcel Brands
XELB
$5.77M
$5.46K ﹤0.01%
+700
New +$7.7K
CGTX icon
6675
Cognition Therapeutics
CGTX
$97M
$5.46K ﹤0.01%
3,000
-18,869
-86% -$39K

Similar funds

Morgan Stanley's Q1 2024 Portfolio in Review

As of Q1 2024, Morgan Stanley held 8,146 positions worth $1.25T, up 9.8% from $1.13T the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Morgan Stanley's Q1 2024 filing shows 340 new, 3,230 increased, 3,352 reduced and 318 closed positions. Its largest new stake was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M. The largest sale was Philip Morris, an estimated $1.42B.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
  • Morgan Stanley added most to UnitedHealth in Q1 2024, an estimated $1.73B increase.
  • Morgan Stanley's biggest Q1 2024 reduction was Philip Morris, cutting an estimated $1.42B.
  • Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $362M.
  • Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
  • Morgan Stanley opened 340 new positions and closed 318 in Q1 2024.
  • Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.25T.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.